26 - Anxiolytics & Hypnotics Flashcards
Summarise GABA Neurotransmission
Precursor is glutamate
Glutamate is converted by glutamate decarboxylase (GAD) to form GABA
- GAD needs vitamin B6 as its co-enzyme
GABA stored in vesicles in pre-synaptic terminals
Action potential arrives in short axon
Depolarisation
Influx of calcium
Exocytotic release of GABA into synaptic cleft
GABA diffuses across cleft
GABA stimulates post-synaptic receptors
- these are chloirde ionophore receptors
- GABAA receptors
- these are type 1 receptors (ion-channel linked)
- these sit on the post-synaptic neurones (often glutamatergic, but could be any other neurone)
GABA is regulating the activity of the post-synaptic neurone
Chloride ions flow into the post-synaptic neurone, hyperpolarisation (around -90mV)
Neurone is more difficult to excite
GABA is mainly removed by synapse by reuptake
- into glial cells or into pre-synaptic neurone
Then is metabolised
- by GABA transaminase
GABAB receptors are mainly pre-synaptic and are mainly regulatory
- if too much GABA release, it acts on these receptors
- this causes less GABA release
Outline GABA metabolism
GABA is firstly reuptaken
Then acted on by catabolic enzymes
Succinic acid is final product
- then goes into TCA cycle in glial cells
GAD is a cytoplasmic enzyme
- only in GABAergic neurones
GABA-T and SSDH are mitochondrial enzymes
Sodium Valproate and Vigabatrin are anti-convulsant drugs and then inhibit GABA metabolism. Raise central GABA levels.
Vigabatrin acts on GABA-T only (covalently)
Sodium Valproate acts on GABA-T and SSDH at therapeutic concentrations. Also, acts on VSSCs so can reduce glutamate release
Describe the structure of the GABAA Receptor Complex
4 main proteins
- GABA receptor protein
- Barbiturate receptor protein
- Chloride channel protein
- Benzodiazepine receptor protein
When GABA binds:
- binds to GABA receptor protein
- causes linkage between GABA receptor protein and BDZ receptor protein
- mediated by GABAmodulin peptide
- this causes transient open of chloride channel
- causes hyperpolarisation
When BDZs bind:
- bind to BDZ receptor protein
- enhance the opening of the channel
- also, in the presence of a BDZ, there is a better binding of GABA to the receptor. this is reciprocated and causes better binding of BDZ
When Barbituates bind:
- binds to barbituate receptor protein
- enhances normal action of GABA
- also in presence of a barbituate, there is better binding of GABA but this is not reciprocated
- at higher doses, they can cause direct opening of chloride channel
Bicuculline:
- competitive GABA receptor antagonist
Flumazenil:
- competitive BDZ antagonist
What effect do BDZs and BARBs have on the GABAA Receptor Complex?
Have no direct action on GABA
Need GABA to be present in order to work
Allosteric action - have their own binding sites of GABAA receptor
BARBs less selective than BDZs
- BARBs may also reduce exictatory transmission, antagonist effects at glutamate receptors
- BARBs can induce social anaesthesia
- BARBs have relatively low margin of safety
BDZs = increase frequency of opening of chloride channel
BARBs = increase duration of chloride channel opening
What are the clinical uses of …?
Anaesthetics - BARBs only
- thiopentone
- inducing agent
- very highly lipid soluble
Anticonvulsants
- diazepam
- epilepsy
- clonazepam
- epilepsy
- phenobarbital
- less used because of side-effects
Anti-Spastics
- diazepam
- relaxation of tension
Anxiolytics
Sedatives/Hypnotics
Define ‘Anxiolytics’
ANXIOLYTICS
Remove anxiety without impairing mental or physical activity
‘Minor Tranquilisers’
Define ‘Sedatives’
SEDATIVES
Reduce mental and physical activity without producing loss of consciousness
Define ‘Hypnotics’
HYPNOTICS
Induce sleep
What characteristics should anxiolytics, sedatives and hypnotics ideally all have?
Ideally they should:
i) HAVE WIDE MARGIN OF SAFETY
ii) NOT DEPRESS RESPIRATION
iii) PRODUCE NATURAL SLEEP (HYPNOTICS)
iv) NOT INTERACT WITH OTHER DRUGS
v) NOT PRODUCE ‘HANGOVERS’
vi) NOT PRODUCE DEPENDENCE
Describe the molecular structures of barbiturates
6 membered ring
Differ in R1, R2 and X
What are the clinical uses of barbiturates?
Range of clinical uses including
- sedative/hypnotic
- amobarbital
- severe intractable insomnia
- half life = 20-25 hours
- intermediate acting BARB
- superceded by BDZs, not gold-standard
What are the unwanted effects of barbiturates?
UNWANTED EFFECTS OF BARBITURATES
NOT 1ST LINE DRUGS
Low Safety Margins
- depress respiration
- overdosing lethal
Alter Natural Sleep
- low REM
- lead to hangovers and irritability
Enzyme Inducers
Potentiate Effects of Other CNS Depressants
- e.g. alcohol
Tolerance
Dependence
- withdrawal syndrome
- insomnia, anxiety, tremore, convulsions, death
Describe the molecular structures of Benzodiazepines
Three-ring structure
Different substituent groups
- relatively small changes between different BDZs leads to big changes in pharmacokinetics
Flumazenil
- antagonist of BDZs
- similar structure to BDZs
How many Benzodiazepines are available and where do they act?
Around 20 available
All act at GABAA Receptors
What determines the use of different Benzodiazepines?
All have similar potencies and profiles
Pharmacokinetics largely determine use